Skip to content
naulon

Not checkedNot checked for notices yet.

Low Dose Radiation Therapy for Covid-19: Benefit or Threat?

Ahlam Almanie, Samaneh Abbasi

JLUMHS · 2021

doi:10.22442/jlumhs.2021.00866 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The new coronavirus outbreak emerged at the end of 2019 worldwide in a very short period of time. The number of victims of this virus until 2020/11/17 has been 1323143. The consequences of these viruses in humans are common cold or mild illness in the upper respiratory region. In more severe cases can causes severe interstitial pneumonia and acute respiratory distress syndrome (ARDS) and Middle East respiratory syndrome (MERS) and, severe acute respiratory syndrome (SARS). So far various drugs have been prescribed and used for the treatment. However, their efficiency and their side effects for treatment of pneumonia of COVID19 are unknown and should be more investigated. Low-dose radiation (LDR) (30 to 100 cGray(Gy)) has been used historically since the early 1930s with hopeful results for pneumonia treatment and was a common treatment solution for viral pneumonia until the 1940s. As some recent studies have raised the use of LDRT for COVID19 treatment, we sought to review previous evidence oftherapeutic role of LDRT in the inflammatory diseases as well as recent recommendations about consider LDRT as the treatment method for COVID19. Based on the available evidence and the background of studies, it seems that choosing a dose 0.3-0.5 Gy in severe cases of the disease, as well as using radiation for the whole body instead of the lungs, can optimize the immune system, and optimizing the immune system will help improve COVID-19.

Abstract licence: CC BY-NC-SA

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.